
Heat Domes Are Hotter and Lingering Longer—Because of the Arctic
CLIMATEWIRE | Temperatures are finally falling in the eastern U.S. as a vicious heat dome begins to subside. But such sweltering early-summer heat will only get more frequent in the years to come.
That's because this week's heat wave — which tumbled century-old temperature records in some areas — was clearly influenced by climate change, scientists say. The heat dome is just one consequence of the "stuck" weather patterns that are on the rise as the planet warms.
A recent study, published June 16 in the scientific journal Proceedings of the National Academy of Sciences, warns of the rising dangers of such long-lasting weather patterns, which can prompt not just heat waves but also heavy rainfall and floods.
On supporting science journalism
If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.
This week, the heat index — or what the temperature actually feels like to human skin — rose well above 100 degrees in many areas. Minneapolis also broke a daily high last set in 1910 when the city hit 96 degrees Saturday, and New York City tied its 1888 record of 96 degrees in Central Park on Monday.
The new study suggests that the phenomenon behind such extreme weather may have a surprising origin: rapid warming, hundreds of miles away, in the icy Arctic.
Researchers from the University of Pennsylvania and Lawrence Berkeley National Laboratory investigated natural atmospheric patterns known as planetary waves. These wobbly air currents meander up and down as they circle the globe — and when they intensify, they sometimes lead to storms or heat domes stagnating in place for days at a time.
The study looked at the frequency of planet wave "resonance events," or temporary intensifications. They found that these kinds of stalled atmospheric patterns have tripled over the last 70 years. At the same time, extreme summer weather — like heat waves and floods — have also grown more common.
Climate models have long predicted that these patterns would occur more frequently with climate change. But the new study is the first to demonstrate that it's already happening, the authors say.
Still, the exact causes of these planetary wave events are an active research topic.
Some research suggests that rapid warming in the Arctic — which is heating up as much as four times faster than the rest of the globe — is altering the atmosphere in ways that shift the jet stream south and affect the planetary waves. Other studies suggest that tropical warming may actually yank the jet stream poleward. And some researchers say planetary waves may be impacted by a tug-of-war between these two influences.
Computer models aren't always able to fully simulate these physical responses, making it a difficult subject to study. Scientists have been investigating — and debating — the exact physical effects of global warming on atmospheric circulation patterns for years.
But the new study adds to the evidence that Arctic warming plays a role. It shows that periods of warmer temperatures in the high latitudes are associated with increases in planetary wave resonance events. It also demonstrates that the growing global contrast between land temperatures and ocean temperatures — since land is warming faster than water worldwide — has also played a part.
Other events have an influence as well, the research suggests. Strong El Niño events, which cause temperatures to warm in the Pacific Ocean, also seem to drive temporary spikes in weather-stalling planetary wave events.
In short, multiple factors — both natural and human-caused — play a role. But climate change is a definite influence, the study notes, warning that extreme summer weather will keep intensifying as global temperatures rise.
Other research also points to the fingerprint of climate change on the recent heat.
Climate Central, a nonprofit climate science and communication organization, has developed a scientific metric known as the Climate Shift Index that evaluates the influence of global warming on temperatures around the world.
The tool estimates that high temperatures in large swaths of the eastern U.S. over the last few days were at least five times more likely to occur because of human-caused climate change.
'The extent of this early summer heat dome over the United States is remarkable,' said Climate Central scientist Zachary Labe in a statement. 'It is a stark reminder that climate change is making these dangerous and oppressive heat waves far more likely, affecting millions of people.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Gizmodo
16 hours ago
- Gizmodo
Notorious Fungus Blamed for ‘Mummy's Curse' Is Now a Promising Cancer Treatment
In the 1920s, a number of workers on the excavation team that uncovered King Tutankhamun's tomb met untimely deaths. Five decades later, 10 out of 12 scientists died after entering the tomb of the 15th-century Polish King Casimir IV. In both cases, researchers suggested that fungal spores could have played a role in the mysterious deaths, specifically identifying the fungus Aspergillus flavus within the Polish burial. A. flavus is now making a comeback, but not as a reawakened killer from ancient tombs, but instead as a surprisingly effective cancer-fighting compound. By modifying a newly identified molecule found in the fungus, the researchers created a compound that performed as effectively against leukemia cells as FDA-approved drugs. The molecules at the center of these anti-cancer properties, known as ribosomally synthesized and post-translationally modified peptides, or RiPPs, are a diverse group of natural molecules assembled by the ribosome (which makes proteins) and later modified by enzymes. They conduct many different biological activities, some of which are already known for their anti-cancer properties. To date, researchers have identified only a handful of RiPPs in fungi—which is significantly less than the thousands previously discovered in bacteria. Part of the problem is that scientists didn't fully understand how fungi create RiPPs. 'The synthesis of these compounds is complicated,' Qiuyue Nie, a postdoctoral fellow at the University of Pennsylvania's Department of Chemical and Biomolecular Engineering, said in a university statement. 'But that's also what gives them this remarkable bioactivity.' Genetic analysis suggested that a specific A. flavus protein could be a source of fungal RiPPs. Sure enough, when Nie and her colleagues turned off the genes responsible for said protein, RiPPs' chemical markers also vanished. Using this approach, the team discovered four different A. flavus RiPPs with a previously undocumented structure of interlocking rings. After researchers purified these RiPPs, which they named asperigimycins, two of the four unique molecules performed well against human leukemia cells without further modifications. When mixed with a lipid (a fatty molecule), a separate RiPPs variant performed as well as cytarabine and daunorubicin, both of which are long-established FDA-approved leukemia drugs. To investigate this lipid's enhancement properties, the researchers went back to turning genes off and on. In this way, they identified a gene associated with the process that lets enough asperigimycins into the cancer cells. 'This gene acts like a gateway,' said Nie, the first author of the study published Monday in Nature Chemical Biology. 'It doesn't just help asperigimycins get into cells, it may also enable other 'cyclic peptides' to do the same.' Cyclic peptides are other chemicals with known medicinal properties. 'Knowing that lipids can affect how this gene transports chemicals into cells gives us another tool for drug development,' Nie added. The researchers also discovered that asperigimycins might disrupt the process of cell division—which is good news for cancer treatment, since cancer consists of uncontrolled cell division. Furthermore, the compounds had little to no effect on breast, liver, or lung cancer cells, as well as on a number of bacteria and fungi. While this might sound like a negative thing, asperigimycins' potentially targeted impact would be an important characteristic for future medications. Moving forward, the researchers aim to test asperigimycins in animal trials. The recent study investigates a promising new cancer therapy, but it also paves the way for future research into fungal medicines. 'Nature has given us this incredible pharmacy,' said Sherry Gao, senior author of the study and an associate professor also in the University of Pennsylvania's Department of Chemical and Biomolecular Engineering. 'It's up to us to uncover its secrets.'
Yahoo
16 hours ago
- Yahoo
Ancient 'pharaoh's curse' fungus shows promise in killing cancer cells
A potentially deadly fungus known as "pharaoh's curse fungus" could offer an unexpected path to fighting cancer, recent research shows. Scientists from the University of Pennsylvania modified molecules from the fungus — which is officially called Aspergillus flavus — to create a new compound and enhance its cancer-killing properties. "Fungi gave us penicillin," said Dr. Xue (Sherry) Gao, an associate professor at UPenn and leader of the study, in a press release. "These results show that many more medicines derived from natural products remain to be found." Single Dose Of 'Magic Mushrooms' Provides 5 Years Of Depression Relief, Researchers Find The findings were published in the journal Nature Chemical Biology. Aspergillus flavus is found in decaying leaves and compost, as well as on trees, plants and some crops, according to Mayo Clinic. Read On The Fox News App While the fungus doesn't endanger most healthy people, it can cause respiratory issues for those who have weakened immune systems or are taking certain medications. Some of the more severe complications of the fungus can include bleeding in the lungs and life-threatening infections in the brain, heart and kidneys, Mayo Clinic stated. After archaeologists opened King Tut's tomb in the 1920s, multiple members of the excavation team died suddenly, fueling rumors of a "curse" upon those who dared interfere with the pharaoh's rest, according to the UPenn press release. Decades later, doctors hypothesized that fungal spores, which had been dormant for thousands of years, could have infected the team. In the 1970s, it happened again, the university stated. A dozen scientists entered another tomb, this time in Poland — and 10 died within a few weeks. Later investigations were said to reveal the presence of Aspergillus flavus in the tomb. Now, the same fungus linked to King Tut's tomb could have the capability to fight leukemia in a new form of cancer therapy. "There are a variety of compounds able to be produced by fungus," Gao told Fox News Digital. These compounds can be toxic to different cells, she noted, depending on the "biological management we are able to mitigate." Cancer Could Be Detected Three Years Before Diagnosis With Experimental Blood Test The study aimed to find a specific kind of compound — ribosomally synthesized and post-translationally modified peptides, or "RiPPs" — within Aspergillus flavus, which was previously shown to be a good source. When this compound is able to enter cancer cells, Gao said, it may be able to stop their growth. "Cancer cells divide uncontrollably," Gao said in the release. "These compounds block the formation of microtubules, which are essential for cell division." When mixed with human cancer cells, two variants of the molecules within these RiPPS were found to have potent effects against leukemia cells, the researchers found. Another variant performed as well as two FDA-approved drugs that have been used for decades to treat leukemia (cytarabine and daunorubicin). Tiffany Troso-Sandoval, M.D., a medical oncologist and cancer care consultant based in New York, cautioned that this study, which was performed on cell cultures, is still in the very early stages. Your Favorite Alcoholic Beverage Could Be Linked To Deadly Form Of Cancer, Study Finds "It's still very far away from being applicable to use in humans with leukemia," Troso-Sandoval, who was not involved in the study, told Fox News Digital. Speaking about RiPPs, the doctor told Fox News Digital, "What they're referring to [in the study] is basically a rare type of bioactive molecule that they have isolated from this fungus." There are multiple subtypes of leukemia, Troso-Sandoval pointed out, including acute and chronic forms. "One treatment might not work on [another] type of leukemia," she noted. Further testing is needed to determine which subtypes may contain the active molecule. The compound explored in the study had little to no effect on breast, liver or lung cancer cells, the researchers noted. This suggests that its disruptive effects only work on certain types of cells, which will be an important consideration when developing medications. Click Here To Sign Up For Our Health Newsletter Looking ahead, the researchers plan to test the fungus' potential in animal models and, ultimately, human trials. Gao told Fox News Digital she is "excited about what nature can create and how it can benefit our society." For more Health articles, visit The study received support from the National Institutes of Health, the University of Pennsylvania, the Welch Foundation, the Houston Area Molecular Biophysics Program, the Cancer Prevention and Research Institute of Texas and the National Science article source: Ancient 'pharaoh's curse' fungus shows promise in killing cancer cells


Fox News
19 hours ago
- Fox News
Ancient 'pharaoh's curse' fungus shows promise in killing cancer cells
A potentially deadly fungus known as "pharaoh's curse fungus" could offer an unexpected path to fighting cancer, recent research shows. Scientists from the University of Pennsylvania modified molecules from the fungus — which is officially called Aspergillus flavus — to create a new compound and enhance its cancer-killing properties. "Fungi gave us penicillin," said Dr. Xue (Sherry) Gao, an associate professor at UPenn and leader of the study, in a press release. "These results show that many more medicines derived from natural products remain to be found." The findings were published in the journal Nature Chemical Biology. Aspergillus flavus is found in decaying leaves and compost, as well as on trees, plants and some crops, according to Mayo Clinic. While the fungus doesn't endanger most healthy people, it can cause respiratory issues for those who have weakened immune systems or are taking certain medications. Some of the more severe complications of the fungus can include bleeding in the lungs and life-threatening infections in the brain, heart and kidneys, Mayo Clinic stated. After archaeologists opened King Tut's tomb in the 1920s, multiple members of the excavation team died suddenly, fueling rumors of a "curse" upon those who dared interfere with the pharaoh's rest, according to the UPenn press release. Decades later, doctors hypothesized that fungal spores, which had been dormant for thousands of years, could have infected the team. In the 1970s, it happened again, the university stated. A dozen scientists entered another tomb, this time in Poland — and 10 died within a few weeks. Later investigations were said to reveal the presence of Aspergillus flavus in the tomb. Now, the same fungus linked to King Tut's tomb could have the capability to fight leukemia in a new form of cancer therapy. "There are a variety of compounds able to be produced by fungus," Gao told Fox News Digital. These compounds can be toxic to different cells, she noted, depending on the "biological management we are able to mitigate." The study aimed to find a specific kind of compound — ribosomally synthesized and post-translationally modified peptides, or "RiPPs" — within Aspergillus flavus, which was previously shown to be a good source. When this compound is able to enter cancer cells, Gao said, it may be able to stop their growth. "Cancer cells divide uncontrollably," Gao said in the release. "These compounds block the formation of microtubules, which are essential for cell division." When mixed with human cancer cells, two variants of the molecules within these RiPPS were found to have potent effects against leukemia cells, the researchers found. Another variant performed as well as two FDA-approved drugs that have been used for decades to treat leukemia (cytarabine and daunorubicin). Tiffany Troso-Sandoval, M.D., a medical oncologist and cancer care consultant based in New York, cautioned that this study, which was performed on cell cultures, is still in the very early stages. "It's still very far away from being applicable to use in humans with leukemia," Troso-Sandoval, who was not involved in the study, told Fox News Digital. Speaking about RiPPs, the doctor told Fox News Digital, "What they're referring to [in the study] is basically a rare type of bioactive molecule that they have isolated from this fungus." There are multiple subtypes of leukemia, Troso-Sandoval pointed out, including acute and chronic forms. "One treatment might not work on [another] type of leukemia," she noted. Further testing is needed to determine which subtypes may contain the active molecule. The compound explored in the study had little to no effect on breast, liver or lung cancer cells, the researchers noted. This suggests that its disruptive effects only work on certain types of cells, which will be an important consideration when developing medications. Looking ahead, the researchers plan to test the fungus' potential in animal models and, ultimately, human trials. Gao told Fox News Digital she is "excited about what nature can create and how it can benefit our society." For more Health articles, visit The study received support from the National Institutes of Health, the University of Pennsylvania, the Welch Foundation, the Houston Area Molecular Biophysics Program, the Cancer Prevention and Research Institute of Texas and the National Science Foundation.